School of Medicine, Nankai University, Tianjin 300071, China.
ACS Appl Bio Mater. 2021 Feb 15;4(2):1920-1931. doi: 10.1021/acsabm.0c01553. Epub 2021 Jan 17.
Colorectal cancer has become one of the malignant tumors with a high rate of morbidity and mortality. Therefore, how to effectively treat colorectal cancer is crucial. Although nanodelivery system has been applied to the therapy of colorectal cancer, the majority of existing nanodelivery systems still have drawbacks such as low biocompatibility and poor targeting ability. In this work, tailor-made cell-based biomimetic nanoplatform was prepared to enhance the targeting and therapeutic effect for colorectal cancer chemo-immunotherapy. First, hollow long persistence luminescence nanomaterials were synthesized with superior background-free bioimaging effect and high drug-loading content. After loaded with cisplatin, the nanoplatform was camouflaged with tailor-made erythrocyte and programmed cell death receptor 1 (PD-1) expressed hybrid cell membrane. animal imaging experiment showed that the nanoplatform camouflaged with hybrid cell membrane not only had excellent immune escapability but also had excellent tumor active targeting ability. anticancer experiments showed that combined chemotherapy and immunotherapy of the nanoplatform could significantly inhibit tumor growth in tumor-bearing mice. In summary, the tailor-made cell-based membrane camouflage produced excellent immune escapability and cancer active targeting ability, providing a modality for biomimetic nanodelivery systems.
结直肠癌已成为发病率和死亡率较高的恶性肿瘤之一。因此,如何有效地治疗结直肠癌至关重要。尽管纳米递药系统已应用于结直肠癌的治疗,但大多数现有的纳米递药系统仍存在生物相容性低、靶向能力差等缺点。在本工作中,制备了定制的基于细胞的仿生纳米平台,以增强结直肠癌化疗-免疫治疗的靶向和治疗效果。首先,合成了具有优越的无背景生物成像效果和高载药含量的中空长余辉纳米材料。载药后,纳米平台被定制的红细胞和程序性细胞死亡受体 1(PD-1)表达的杂交细胞膜伪装。动物成像实验表明,伪装有杂交细胞膜的纳米平台不仅具有优异的免疫逃逸能力,而且具有优异的肿瘤主动靶向能力。抗癌实验表明,该纳米平台的联合化疗和免疫治疗能显著抑制荷瘤小鼠的肿瘤生长。综上所述,定制的基于细胞的膜伪装具有优异的免疫逃逸能力和癌症主动靶向能力,为仿生纳米递药系统提供了一种新方法。